Sage: How a $433M AI Healthcare Pioneer Is Reshaping the Industry

Executive Summary

Sage is a AI Healthcare company founded in null and headquartered in New York, NY. Led by (), the company has raised a total of $65M across 1 funding round(s), reaching a valuation of $433M. AI-powered integrated technology platform for senior care communities, combining next-generation nurse call systems, fall detection, and data-driven care insights.

The AI funding landscape continues to evolve rapidly, with significant capital flowing into companies pushing the boundaries of artificial intelligence. This period's activity reflects both growing investor confidence and the increasing maturity of the ecosystem. Deal sizes and valuations continue to climb as AI transitions from experimental technology to core enterprise infrastructure.

Company Overview

Sage provides an integrated technology platform for senior living communities that combines AI-powered nurse call systems, fall detection, elopement management, and care analytics. The platform serves independent living, assisted living, memory care, and skilled nursing facilities, reporting outcomes including 75% reduction in fall-related hospitalizations and 50%+ reduction in response time.

This area of the AI market continues to attract significant investor attention, reflecting the sector's rapid growth and substantial long-term potential.

Funding History

Sage has raised a total of $65M across 1 round(s). Below is a complete breakdown of every known funding round.

Total Capital & Valuation

• Total Raised: $65M
• Latest Valuation: $433M (as of Mar 6, 2026)
• Latest Round: Undisclosed — $65M (Mar 6, 2026)
• Number of Rounds: 1

The funding trajectory demonstrates accelerating momentum, with round sizes and valuations increasing as key milestones are delivered and market presence expands.

Key Investors

Sage has attracted 1 known investor(s) across its funding rounds. Below is a profile of each.

Undisclosed

> Undisclosed is an investor in AI companies.

• Type: VC
• Participated in: Undisclosed
• Led: Undisclosed
• View investor profile on AI Funding

The investor composition signals strong institutional backing and strategic interest. The presence of repeat investors alongside new participants suggests growing confidence in execution and market trajectory.

Sector Analysis: AI Healthcare

Sage operates in the AI Healthcare sector (specifically Senior Care Technology). Understanding the broader sector landscape provides context for the company's position and growth potential.

Other companies in the AI Healthcare sector tracked by AI Funding:

Looking ahead, deal activity is expected to remain strong as major AI companies continue scaling operations and new entrants attract institutional capital. Key areas to watch include frontier model development, enterprise AI adoption, and infrastructure plays that underpin the broader ecosystem.

Competitive Landscape

Sage competes with 18 other tracked AI Healthcare companyies in our database:

• Science Corp.: Science Corp. is a clinical-stage neurotechnology company developing the Science Eye, a brain-computer interface retinal implant designed to restore functional vision for patients with degenerative eye diseases. Founded by Max Hodak, co-founder of Neuralink, the company combines AI-driven neural decoding with advanced bioelectronics to tackle one of the hardest problems in neural engineering.
• CareFam: AI-powered healthcare hiring marketplace that matches clinicians with permanent positions using automated sourcing, screening, and onboarding. CareFam addresses the chronic staffing shortage in healthcare by using AI to match nurses, physicians, and allied health professionals with hospitals and clinics based on credentials, preferences, and cultural fit, reducing time-to-hire and improving retention rates.
• Waiv: Owkin spinout developing AI models that analyze routine histopathology slides to detect and characterize cancer, bringing precision oncology diagnostics to standard clinical workflows.
• HEARTio: Develops an artificial intelligence platform designed to analyze electrocardiograms (ECG) for the early detection and prediction of heart attacks to improve cardiovascular outcomes.
• Rivia: Builds an AI engine to analyze clinical trial data and surface insights to help research stakeholders accelerate study decision-making.
• Health Universe: Builds interpretable healthcare AI tools designed to meet regulatory transparency requirements for clinical and compliance stakeholders.
• Parallel: Uses AI to automate and streamline hospital administrative workflows, aiming to reduce administrative burden by around 30%.
• VITL: Builds software to overhaul cash-pay clinic prescribing workflows, capitalizing on demand driven by the GLP-1 medication boom.
• Connectome Health: Builds AI-enabled neurotechnology that tracks brain changes in real time to support clinical monitoring, diagnosis and research into neurological conditions.
• Generare: Builds AI-driven molecular design tools to accelerate generation of novel small molecules for drug discovery, aiming to increase molecule output tenfold by 2027.
• STORM Therapeutics: Develops and advances therapeutic drug candidates for cancer, now progressing a lead program into Phase 2 clinical trials after a $56M Series C financing.
• TriFetch: Uses AI to automate paperwork and administrative workflows for specialty clinics, reducing manual clerical burden and speeding patient throughput.
• PlaqueTec: Develops AI-driven precision medicine tools aimed at improving assessment and management of cardiovascular disease by supporting personalized diagnosis and treatment decisions.
• XCaliber Health: Automates healthcare administrative tasks using AI to streamline workflows, reduce burden, and improve operational efficiency.
• Moonlight AI: Converts routine blood and cytology images into genomic insights using AI to infer molecular information from standard clinical imaging workflows.
• Ditto: Builds AI tools to help patients recall and understand what doctors said during appointments, improving post-visit comprehension and follow-up.
• Saile: An AI platform that helps physicians discover and match with part-time and side-job opportunities, combining clinician expertise with AI-driven job discovery.
• UroMems: Develops a next-generation implantable medical device to treat urinary incontinence, aiming to improve patient outcomes and expand therapeutic options.

At a valuation of $433M, Sage ranks behind Science Corp., STORM Therapeutics in sector valuation.

The competitive landscape remains dynamic, with established players and well-funded startups vying for market share. Differentiation increasingly comes from technology depth, go-to-market execution, and strategic partnerships that provide distribution advantages.

Revenue & Growth

Revenue run rate data is not publicly available for Sage at this time.

Revenue growth has been a key driver of investor interest, with strong product-market fit and expanding enterprise customer adoption underpinning the company's valuation trajectory.

Leadership

,

Sage was founded in null by **, who serves as . Under 's leadership, the company has grown to approximately an undisclosed number of employees and raised $65M in total funding.

Under current leadership, the company has navigated rapid growth while maintaining technical excellence and a clear strategic vision for the future of AI.

Frequently Asked Questions

How much funding has Sage raised?

Sage has raised a total of $65M across 1 funding round(s). The most recent round was a Undisclosed of $65M on Mar 6, 2026.

What is Sage's valuation?

As of its most recent funding round (Undisclosed, Mar 6, 2026), Sage is valued at $433M.

Who are Sage's investors?

Sage's investors include Undisclosed. These investors have collectively committed $65M across 1 round(s).

When was Sage founded?

Sage was founded in null by and is headquartered in New York, NY.

What sector does Sage operate in?

Sage operates in the AI Healthcare sector, specifically in Senior Care Technology. Other companies in this sector include Science Corp., CareFam, Waiv, HEARTio, Rivia, Health Universe, Parallel, VITL, Connectome Health, Generare, STORM Therapeutics, TriFetch, PlaqueTec, XCaliber Health, Moonlight AI, Ditto, Saile, UroMems.

Who is the CEO of Sage?

** is the of Sage.